Hardware Podcasts

#432: China MedTech Compliance: Regulatory Risks, Rewards, & Strategy with Elaine Tan

Global Medical Device Podcast · 10 Nov 2025 · 40m · Episode 432

What this episode covers

Elaine Tan, creator of MedTech Chopsticks, explains the regulatory and strategic complexities of entering the Chinese medical device market, highlighting the NMPA's 2021 overhaul and the 'China for China' policy. She details the necessity of local type testing, the dual-strategy approach for IP protection, and the critical requirement for agents to hold an NMPA-approved CA USB key for electronic submissions. The discussion covers leveraging the Hainan Free Trade Zone for real-world data collection and the importance of gap analysis against Chinese Product Technical Requirements (PTR).

Most relevant to

early-stage companies

Topics

Mentioned

Products
MedTech Chopsticks
Also
NMPA, Hainan Free Trade Zone, CA USB key, CDMO, CMO, PTR

Related episodes from other shows

Other shows on the same ground, closest first.

  • Let's Combinate · 29m

    226 - Navigating China NMPA Medical Device Requirements | Standards, GMP Updates, Agents & Classification

    Elaine (Yi Ling Tan) of MedTech Chopsticks explains that Western manufacturers often fail in China because they assume EU or US approvals (IEC/ISO, FDA) translate directly, whereas China requires compliance with local GB (national) and YY (industry) standards. She details the necessity of local type testing using Product Technical Requirements (PTRs) and highlights that China’s GMP differs from ISO 13485, particularly with upcoming dual market release requirements in November 2026. The conversation covers the critical role of China agents in managing NMPA-designated testing labs, clinical evaluation predicates, and post-market surveillance, noting that misclassification changes every two years can drastically alter regulatory strategy.

    Certification & complianceManufacturing partners & offshoring
    9 chapters

  • OnTrack · 45m

    Supply Chain Challenges in Medical Device Manufacturing

    Supply chain executive Simon Hinds discusses the unique complexities of medical device and life sciences supply chains, contrasting them with automotive and consumer electronics. He explains how regulatory barriers, traceability requirements like CFR 21 Part 11, and mutual recognition agreements impact sourcing and manufacturing strategies. Hinds details the challenges of scaling from prototype to volume, managing tier 1-3 supplier risks, and navigating geopolitical tariffs through diversification and postponement strategies.

    Sourcing & supply chainCertification & compliance
    8 chapters

  • Let's Combinate · 21m

    216 - How UAE and Singapore Are Redefining Regulatory Innovation with Stephen O'Rourke

    Stephen O'Rourke, founder of the consultancy Clarifi, discusses regulatory strategy for MedTech, biotech, and novel food startups navigating EU and US pathways. He highlights the hidden costs of regulatory failure, emphasizing the need for early engagement with agencies and the importance of UDI compliance across all departments. O'Rourke also explores emerging regulatory models in the UAE and Singapore, explaining how regulatory sandboxes and national initiatives are accelerating innovation, and shares insights from his run for the European Parliament on how policy is made.

    Policy, trade & tariffsCertification & compliance
    7 chapters

  • Let's Combinate · 59m

    027 - "Become a Historian of the Problem" with Duane Mancini

    Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

    Crowdfunding & preordersValidation & product-market fit
    8 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.